Artemisinin enhances the anti-tumor immune response in 4T1 breast cancer cells in vitro and in vivo-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Artemisinin enhances the anti-tumor immune response in 4T1 breast cancer cells in vitro and in vivo

Published:2019-05 Issue: Volume:70 Page:110-116
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Cao Yu,Feng Yong-Hui,Gao Li-Wei,Li Xiao-Ying,Jin Quan-Xiu,Wang Yu-Ying,Xu Ying-Ying,Jin Feng,Lu Shi-Long,Wei Min-Jie

Funder

China Postdoctoral Science Foundation

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference50 articles.

1. Global cancer statistics;Jemal;CA Cancer J. Clin.,2011

2. Clinical outcomes in patients with node-negative breast cancer treated based on the recurrence score results: evidence from a large prospectively designed registry;Stemmer;NPJ Breast Cancer,2017

3. 20-Year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years;Pan;N. Engl. J. Med.,2017

4. Molecular portraits of human breast tumours;Perou;Nature,2000

5. Long term side effects of adjuvant chemotherapy in patients with early breast cancer;Tao;Breast,2015

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review on effects and mechanisms of plant-derived natural products against breast cancer bone metastasis;Heliyon;2024-09

2. Mechanism of Self-Assembled Celastrol-Erianin Nanomedicine for treatment of breast cancer;Chemical Engineering Journal;2024-09

3. Effects of artemisinin and cisplatin on the malignant progression of oral leukoplakia. In vitro and in vivo study;Journal of Cancer Research and Clinical Oncology;2024-08-18

4. Natural products as promising modulators of breast cancer immunotherapy;Frontiers in Immunology;2024-07-10

5. Cancer Immunotherapy with “Vascular-Immune” Crosstalk as Entry Point: Associated Mechanisms, Therapeutic Drugs and Nano-Delivery Systems;International Journal of Nanomedicine;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3